MedPath

Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis

Completed
Conditions
Osteonecrosis
Interventions
Other: Observational
Registration Number
NCT00601068
Lead Sponsor
University of Florida
Brief Summary

In cooperation with Merck \& Co, Inc. we will identify and form a database of 35 patients who have developed osteochemonecrosis of the jaws related to oral bisphosphonate use. We will study the triggers, associated medical conditions and medications, location of the lesion(s), and patient outcomes.

Detailed Description

This study is an observational study, and not a comparative trial. The major outcome is represented by the fraction of subjects with long term healed lesions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Exposed bone in the oral cavity of greater than 6-8 weeks duration unresponsive to therapy
Exclusion Criteria
  • Pregnant patients
  • Patients less than 30 yrs of age or greater than 90 yrs of age
  • Mentally incompetent individuals

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ObservationalObservationalGroup of patients with osteochemonecrosis related to oral bisphosphonate use
Primary Outcome Measures
NameTimeMethod
establish complete database and publish descriptive paper2 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath